Duopharma Biotech Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	290.87	264.55	270.5	157.64	137.98
Cash & Short-Term Investments	290.87	264.55	270.5	157.64	137.98
Cash Growth	9.95%	-2.20%	71.60%	14.25%	-12.69%
Accounts Receivable	216.02	184.33	135.04	131.31	122.42
Other Receivables	16.63	23.59	26.38	10.84	10.31
Receivables	232.65	207.92	161.42	142.15	132.72
Inventory	293.17	248.55	243.07	235.18	222.19
Prepaid Expenses	3.33	5.39	2.08	6.52	1.9
Total Current Assets	820.02	726.4	677.07	541.49	494.8
Property, Plant & Equipment	554.11	567.52	582.37	579.92	542.53
Long-Term Investments	16.48	22.67	36.91	42.15	73.54
Other Intangible Assets	6.37	7.32	7.65	3.84	4.95
Long-Term Deferred Tax Assets	22.62	15.33	8.95	13.33	12.7
Long-Term Deferred Charges	30.52	37.55	31.15	40.14	34.58
Other Long-Term Assets	1.05	1.05	1.05	1.05	1.05
Total Assets	1,451	1,378	1,345	1,222	1,164
Accounts Payable	53.98	55.89	40.45	51.93	31.32
Accrued Expenses	83.4	46.92	33.79	40.46	61.2
Short-Term Debt	29.09	32.33	50.59	101.8	87.85
Current Portion of Long-Term Debt	118.34	15.66	14.95	32.34	15.08
Current Portion of Leases	0.72	0.55	0.92	0.94	0.64
Current Income Taxes Payable	4.29	0.74	0.37	1.17	6.06
Other Current Liabilities	25.14	25.89	25.65	35.95	28.17
Total Current Liabilities	314.96	177.99	166.73	264.59	230.31
Long-Term Debt	345.47	464.52	480.9	294.6	297.8
Long-Term Leases	2.47	2.76	1.48	1.92	2.48
Long-Term Deferred Tax Liabilities	30.64	23.42	8.91	5.58	9.54
Total Liabilities	693.54	668.68	658.01	566.7	540.13
Common Stock	432.47	432.47	432.47	419.37	405.86
Retained Earnings	408.57	354.78	319.07	288.37	239.97
Comprehensive Income & Other	-83.41	-78.09	-64.41	-52.52	-21.82
Shareholders' Equity	757.62	709.15	687.12	655.22	624
Total Liabilities & Equity	1,451	1,378	1,345	1,222	1,164
Total Debt	496.08	515.82	548.85	431.6	403.84
Net Cash (Debt)	-205.21	-251.28	-278.35	-273.97	-265.86
Net Cash Per Share	-0.21	-0.26	-0.29	-0.29	-0.29
Filing Date Shares Outstanding	961.94	961.94	961.94	952.24	941.77
Total Common Shares Outstanding	961.94	961.94	961.94	952.24	941.77
Working Capital	505.07	548.42	510.34	276.9	264.49
Book Value Per Share	0.79	0.74	0.71	0.69	0.66
Tangible Book Value	751.26	701.84	679.47	651.38	619.06
Tangible Book Value Per Share	0.78	0.73	0.71	0.68	0.66
Land	65.68	65.68	65.68	69.88	69.88
Buildings	269.88	267.09	265.86	125.23	124.51
Machinery	467.96	452.39	435.18	368.47	308.94
Construction In Progress	14.52	12.19	8.48	172.65	162.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.